Midodrine Medical Valley (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Medical Valley, is a Alpha-1 adrenergic agonist presented as an oral tablet for oral administration. It belongs to the antihypotensive/vasopressor therapeutic class and is indicated for the treatment of orthostatic hypotension, helping to increase standing blood pressure and reduce dizziness in adult patients.

GNH USA supplies Midodrine Medical Valley as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The company adheres to stringent quality standards and offers comprehensive logistics support for global distribution.

Midodrine is employed to manage conditions characterized by inadequate blood pressure regulation, primarily within the orthostatic hypotension spectrum, including both primary and secondary forms. - Orthostatic hypotension: Improves standing systolic pressure and significantly reduces dizziness, syncope, and fatigue in affected adults. - Neurogenic orthostatic hypotension: Increases peripheral vascular resistance to alleviate symptoms caused by autonomic failure. - Dialysis-related hypotension: Supports blood pressure maintenance during hemodialysis sessions, reducing intradialytic symptoms. - Severe chronic hypotension: Provides adjunctive therapy when conventional measures fail to achieve target pressures. - Postural tachycardia syndrome (POTS): Off‑label use to improve blood pressure, though evidence is limited.

Midodrine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Piloerection (goosebumps): localized skin reaction often seen shortly after dosing. - Itching (pruritus): mild to moderate discomfort that may affect the trunk or limbs. - Urinary retention: difficulty initiating or completing urination, especially in patients with prostate enlargement. - Supine hypertension: elevation of blood pressure while lying down, requiring monitoring.

Serious or Rare Side Effects: - Severe hypertension: abrupt and marked rise in blood pressure that can lead to vascular events. - Cardiac arrhythmia: irregular heart rhythms, including tachycardia or bradycardia, potentially symptomatic. - Ischemic colitis: rare intestinal ischemia presenting with abdominal pain and bloody stools. - Anaphylaxis: life‑threatening allergic reaction with rash, swelling, and respiratory compromise.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly. - Assess blood pressure: obtain supine and standing measurements to confirm orthostatic hypotension. - Avoid use in severe cardiac disease: monitor for excessive hypertension or cardiac strain. - Review concomitant antihypertensives: adjust doses to prevent overly high blood pressure. - Caution in renal impairment: consider dose modification in patients with reduced kidney function. - Monitor for urinary retention: especially in males with known prostate enlargement. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Midodrine can interact with several drug classes, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): combined effect may cause dangerous hypertension. - Other vasopressors (e.g., phenylephrine): additive pressor effect can lead to severe blood pressure spikes. - Tricyclic antidepressants: increase risk of supine hypertension due to synergistic α‑adrenergic activity.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate orthostatic hypotension when therapy is withdrawn. - Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): require careful blood pressure monitoring to avoid excessive lowering.